Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Noevir Holdings Co's revenue for the
three
months ended in Mar. 2026 was 円15,149 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was 円63,302 Mil.
Noevir Holdings Co's Revenue per Share for the
three
months ended in Mar. 2026 was 円443.52.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円1,853.68.
Warning Sign:
Noevir Holdings Co Ltd revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Noevir Holdings Co was -1.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 1.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 5.30% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 2.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Noevir Holdings Co's highest 3-Year average Revenue per Share Growth Rate was 29.40% per year. The lowest was -25.20% per year. And the median was 3.60% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Noevir Holdings Co Revenue Related Terms
Noevir Holdings Co Revenue Historical Data
* Premium members only.
The historical data trend for Noevir Holdings Co's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Noevir Holdings Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Noevir Holdings Co Revenue vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Noevir Holdings Co's Revenue distribution charts can be found below:
* The bar in red indicates where Noevir Holdings Co's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円63,302 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Noevir Holdings Co (TSE:4928) has a Revenue of 円63,302 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Noevir Holdings Co and its competitors.
Is Noevir Holdings Co's Revenue too high?
Noevir Holdings Co's current Revenue is 円63,302 Mil. Overall, Noevir Holdings Co has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Noevir Holdings Co's Revenue compare to PG and CL?
Noevir Holdings Co's Revenue of 円63,302 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Consumer Packaged Goods company?
A good Revenue depends on the Consumer Packaged Goods industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Noevir Holdings Co and its competitors. Noevir Holdings Co's current Revenue is 円63,302 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Noevir Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Noevir Holdings Co (TSE:4928) is currently considered Fairly Valued. The stock's GF Value™ is 円4,974.20, compared to a current price of 円4,825.00 — trading 3% below its estimated fair value. The current Revenue is 円63,302 Mil. Noevir Holdings Co's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Noevir Holdings Co (TSE:4928), the current Revenue is 円63,302 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Noevir Holdings Co (TSE:4928) Overvalued in 2026?
Based on GuruFocus' analysis, Noevir Holdings Co stock appears to be undervalued.
The current stock price of 円4,825.00 is trading 3% below its estimated GF Value™ of 円4,974.20.
GuruFocus considers Noevir Holdings Co to be Fairly Valued.
Key valuation signals for TSE:4928:
Revenue: 円63,302 Mil
GF Value™: 円4,974.20 vs. price of 円4,825.00 (3% below fair value)
No single metric tells the full story. See the TSE:4928 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses: cosmetics and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number of brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces, and sells a broad range-of-products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in many countries across the world and focuses on developing Asian markets.
88GF Score
Get the complete analysis for TSE:4928
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4928 has been successfully added to your 
